Skip to main content

Table 1 BACE1 CSF-based biomarkers

From: β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification

BACE1 activity measured (method)

 Antibody

Substrate

Clinical study

Result

Sandwich ELISA

Anti-BACE1 Ab SECB1&2 [56, 57]

Anti-BACE1 Ab B280 and anti-BACE1 monoclonal Ab (R&D Systems Inc) [58]

Synthetic fluorescence substrate—containing the BACE1 cleavage site

Zhong et al. [59]

Significant elevation of BACE1 levels in MCI and AD

Strong and significant correlation of BACE1 activity with BACE1 protein and Aβ peptide level

Solution-based detection of CSF BACE activity

Polyclonal NF neoepitope-specific Ab [60]

Biotinylated BACE1 substrate

Zetterberg et al. [10]

Significant differences in BACE1 activity between MCI, AD, and HC

Positive correlation between BACE1 activity, CSF t-tau, and Aβ40 levels in the MCI and AD

Sandwich ELISA

Anti-BACE1 Ab SECB1&2 [56, 57]

Anti-BACE1 Ab B280 and anti-BACE1 monoclonal Ab (R&D Systems Inc) [58]

Synthetic fluorescence substrate—containing the BACE1 cleavage site [59]

Ewers et al. [11]

BACE1 activity and protein levels were significantly increased in AD compared to healthy HC

Increase in CSF BACE1 activity in AD

Increased activity associated with increased CSF t-tau but not Aβ42 in AD

2 step-solution-based detection of CSF BACE activity

Anti-NF c-terminal neoepitope polyclonal Ab

Biotinylated peptide substrate (bBACE (aa1–460)) and Sapphire-II Enhancer substrate

Perneczky et al. [14]

Savage et al. [15]

No significant difference in BACE1 levels between HC, MCI, and AD

ELISA

mAbs ADx401 (clone 5G7) and 10B8 and mAb ADx402 (clone 10B8F1) biotinylated with peroxidase [26]

 

De Vos et al. [18]

Significant correlation of ratio of CSF neurogranin trunc P75/BACE1 between HC, MCI, and AD

Solution-based assay

BACE1 Activity Assay Kit (Sigma CS1060)

BACE1 Activity Assay Kit (Sigma CS1060)

Mulder et al. [16]

No significant differences in BACE1 levels between MCI, AD, and HC

SignalClimb technology

Time-resolved fluorescence activity [61]

Synthetic TruePoint BACE1 substrate

Tsolakidou et al. [62]

Positive correlation between BACE1 activity and SORL1 in CSF t-tau and sAPPβ levels in AD

Sandwich ELISA

Anti-BACE1 monoclonalAbs (mAbs) 5G7 and 10B8 [26]

 

Timmers et al. [19]

CSF BACE1 correlated positively with age (weak) and with Aβ37 (strong), sAβPP-total, p-tau181 (strong)

Commercially available assays

Euroimmun, Luebeck, Germany

 

Schaeverbeke et al. [20]

Correlation of BACE1 activity with brain volumes and Aβ load in regions typically involved early in AD

SignalClimb technology

Time-resolved fluorescence activity [61]

Synthetic TruePoint BACE1 substrate

Grimmer et al. [21]

Strong association between BACE1 activity and in vivo Aβ pathology in brain regions close to the ventricles

Solution-based detection of CSF BACE activity

Polyclonal NF neoepitope-specific Ab [59]

Biotinylated BACE1 substrate

Rosén et al. [12]

BACE1 correlated slightly with sAPPα, sAPPβ, and Aβ40

2 step ELISA

Time-resolved fluorescence activity [61]

Synthetic TruePoint BACE1 substrate

Alexopoulos et al. [63]

No significant difference in BACE1 activity between AD and HC or MCI while BACE1 activity was significantly higher in MCI-AD compared to both HC

Solution-based detection of CSF BACE activity

Fluorescence-based detection in the presence of inhibitor Calbiochem

Synthetic peptide substrates containing the BACE 1 cleavage site

Ewers et al. [31]

CSF BACE1 activity significantly increased in MCI compared to AD. No significant difference between AD and HC

BACE activity fluorometric assay kit

K360-100, BioVision, Milpitas, CA, USA

 

Hou et al. [32]

BACE1 activity significantly increased in the hippocampus of ApoE4/3xTg mice especially in females

Sandwich ELISA

Used anti-BACE1 ectodomain MAB9311 (R&D Systems) and detection with rabbit anti-BACE1 N-terminus B0681 (Sigma–Aldrich) Abs [64]

 

Decourt et al. [42]

BACE1 levels 12% lower in the AD frontal cortex compared to HC

6.5% decrease in the temporal cortex

Solution-based assay

Used modified procaspase-3 as detection enzyme

Caspase substrate AspGluValAsp-p-nitroanilide

Verheijen et al. [65]

Assay detects BACE1 activity in extracts of human brain tissue and CSF

  1. Abbreviations: CSF cerebral spinal fluid, MCI individuals with mild cognitive impairment, AD patients with Alzheimer’s disease dementia, HC cognitively healthy individuals, ELISA enzyme-linked immunosorbent assay, Ab antibody, t-tau total peptide tau protein, amyloid beta, BACE1 beta secretase1